Personal profile
Education
- 2009-2012 M.S., EMBA, College of Management, National Taiwan University
- 1991-1994 Ph.D., Department and Graduate Institute of Pharmacology, National Taiwan University
- 1989-1991 M.S., Department and Graduate Institute of Pharmacology, National Taiwan University
- 1986-1989 B.S., School of Pharmacy, Taipei Medical University, Taipei Medical College
Experience
- 2025.03- Principal Investigator, Center for University Social Responsibility Ministry of Education
- 2024.03- President, The Pharmacological Society in Taiwan
- 2019.11- Board Member, Institute for Biotechnology and Medicine Industry
- 2024.11- Board Director, Formosa Cancer Foundation
- 2023.05- Board Director, Dr. Tsungming Tu Foundation
- 2019.10- Board Director, Professor C. Y. Lee Foundation
- 2024.10-2025.03 Visiting Professor, University of California, San Francisco
- 2024.04-2024.09 Visiting Professor, Imperial College London
- 2020.06-2024.03 Executive Board Member, The Pharmacological Society in Taiwan
- 2019.07-2025.06 Board Director, Center for Drug Evaluation , Taiwan
- 2018.07-2023.07 Board Director, The Foundation for International Cooperation in Higher Education of Taiwan
- 2018.03-2024.02 Board Director, National Institutes of Applied Research
- 2018.02- Professor, International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University
- 2018.02- Professor, International Ph.D. Program for Cell Therapy and Regeneration Medicine, Taipei Medical University
- 2017.10-2022.01 Board Member, Association of Private Universities and Colleges
- 2017.08-2023.07 President, Taipei Medical University
- 2016.11-2017.10 Professor, International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University
- 2016.08-2017.07 Professor, Ph.D. Program in Biotechnology Research and Development, Taipei Medical University
- 2016.02-2016.07 Acting Dean, College of Management, Taipei Medical University
- 2014.11-2017.07 Vice President, Taipei Medical University
- 2014.07-2017.07 Chairman, Green Health Biotech Co., Ld.
- 2014.04-2017.07 Chairman, TMU International Biotech Co., Ltd.
- 2014.02- Professor, The Ph.D. Program for Translational Medicine, Taipei Medical University
- 2011.10-2014.10 Chief Secretariat, Taipei Medical University
- 2009.09- Professor, School of Pharmacy, Taipei Medical University
- 2009.08-2011.09 Dean, Office of Academic Affairs, Taipei Medical University
- 2009.08-2010.07 Director, Center for General Education, Taipei Medical University
- 2007.08-2009.01 Director, Graduate Institute of Medical Sciences, Taipei Medical University, Taiwan
- 2004.09-2007.07 Director, School of Medicine, Taipei Medical University
- 2004 Director, Graduate Institute of Medical Sciences, Taipei Medical University
- 2004.08- Professor, Graduate Institute of Medical Sciences, Taipei Medical University
- 2003.09-2004.07 Director, Office of Business Development, Taipei Medical University
- 2003.09-2009.07 Dean, Office of Research and Development, Taipei Medical University
- 2002.08-2004.07 Professor, Graduate Institute of Biomedical Technology, Taipei Medical University
- 2001.08-2004.09 Director, School of Respiratory Therapy, Taipei Medical University
- 1997.07-2002.07 Associate Professor, Graduate Institute of Biomedical Technology, Taipei Medical University
- 1995.07-1997.05 Postdoctoral, Department/Institute of Physiology & Biophysics
- 1995.01-1995.06 Postdoctoral, Department of Pharmacology, College of Medicine, National Taiwan University
Awards
- 2011-2017、2021-2024 NSC/MOST Special Outstanding Talent Award
- 2011、2013、2018、2022The Major Research Program Award, Taipei Medical University
- 2016 The Total Expenditure of Projects Research Awards, Taipei Medical University
- 2011,2012,2013,2014 NSC Outstanding
- 2014 The Major Research Program Award, Taipei Medical University
- 2013 The Annual Research Achievement Award, Taipei Medical University
- 2013 The Outstanding International Paper Award, Taipei Medical University
- 2013 The Most Influential Paper Award, Taipei Medical University
- 2012 The Major Research Program Award, Taipei Medical University
- 2009 The Gold Research Award, Taipei Medical University
- 2005 The Outstanding Research Award, Taiwan Pharmacology Society
- 2004 The Gold Research Award, Taipei Medical University
- 2002 The Silver Research Award, Taipei Medical University
- 1998,1999,2000 Research Award, NSC
- 1994 The 5Th Annual Wang Ming-Ning Award
Research Interests
- Cell Biology
- Molecular Mechanism of Lung Fibrosis & Inflammation
- Signal Transduction
- New Drug Development
Related Link
Fingerprint
Dive into the research topics where Chien-Huang Lin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
The Pathophysiological Roles of Interleukin-21 Receptor (Il-21r) in Idiopathic Pulmonary Fibrosis
Lin, C.-H. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
The Molecular Mechanism of Bicaudal-C (Bicc) Family Rna Binding Protein 1 (Bicc1)-Regulated Impairment of Epithelial Integrity in Bronchial Ciliated Epithelial Cell of T2-Low Severe Asthma( I )
Lin, C.-H. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
The Pathophysiological Roles of Interleukin-21 Receptor (Il-21r) in Idiopathic Pulmonary Fibrosis
Lin, C.-H. (PI)
8/1/23 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
教育部大學社會責任實踐計畫管考成果推廣及培力輔導作業
Lin, C.-H. (PI)
2/21/25 → 2/28/26
Project: A - Government Institution › d - Ministry of Education
-
Doublecortin like kinase protein 1 (DCLK1)在支氣管肺纖維化中的病理生理學研究－Doublecortin like kinase 1 (DCLK1) / Notch1調控嚴重氣喘患者循環纖維球活化的分子病理機轉(3/3)
Lin, C.-H. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
Involvement of ADAM17-dependent MUC1-CT activation in TGF-β-induced EZH2 expression in human lung fibroblasts and in ovalbumin-induced airway fibrosis in mice
Hua, H. S., You, J. J., Wu, Y. C., Chen, J. Y., Lee, H. S., Chen, B. C. & Lin, C. H., Sept 2025, In: Biochemical Pharmacology. 239, p. 117036 117036.Research output: Contribution to journal › Article › peer-review
-
Role of C/EBPβ/STAT3/AP-1 transcriptional complex formation in thrombin-induced connective tissue growth factor expression in human lung fibroblasts
Hua, H. S., Huang, Y. T., Lee, H. S., Liu, C. H., Chao, W., Chen, B. C. & Lin, C. H., Nov 5 2025, In: European Journal of Pharmacology. 1006, 178178.Research output: Contribution to journal › Article › peer-review
-
Serine/threonine kinase 33 mediates thrombin-induced interleukin-8 release from human lung epithelial cells in severe asthma
Cheng, W. H., Chang, W. S., Feng, P. H., Chen, K. Y., Lee, K. Y., Wu, Y. C., Lin, L. Y., Yuliani, F. S., Lin, C. H. & Chen, B. C., Dec 2025, In: Respiratory Research. 26, 1, 288.Research output: Contribution to journal › Article › peer-review
Open Access -
MPT0E028, a novel pan-HDAC inhibitor, prevents pulmonary fibrosis through inhibition of TGF-β-induced CTGF expression in human lung fibroblasts: Involvement of MKP-1 activation
Liu, C. H., Lee, H. S., Liou, J. P., Hua, H. S., Cheng, W. H., Yuliani, F. S., Chen, B. C. & Lin, C. H., Aug 15 2024, In: European Journal of Pharmacology. 977, p. 176711 176711.Research output: Contribution to journal › Article › peer-review
5 Link opens in a new tab Citations (Scopus) -
Neutralization of CX3CL1 Attenuates TGF-β-Induced Fibroblast Differentiation Through NF-κB Activation and Mitochondrial Dysfunction in Airway Fibrosis
Cheng, W. H., Chang, P. L., Wu, Y. C., Wang, S. A., Chen, C. L., Hsu, F. L., Neoh, M. M., Lin, L. Y., Yuliani, F. S., Lin, C. H. & Chen, B. C., Jun 2024, In: Lung. 202, 3, p. 343-356 14 p.Research output: Contribution to journal › Article › peer-review
9 Link opens in a new tab Citations (Scopus)